Stryker invests $400M in CMR Surgical with option to buy company

Stryker has invested about $400 million in U.K.-based CMR Surgical and secured an exclusive option to acquire the company's remaining equity. Stryker also became the exclusive U.S. sales agent for the Versius surgical robot, which has been used in 45,000 cases across more than 30 countries.

• Stryker's investment in CMR Surgical totals about $400 million
• Stryker holds an exclusive option to buy 100% of CMR's equity
• Versius has been used in 45,000 cases in over 30 countries
• Versius Plus has FDA 510(k) clearance for cholecystectomy